hemocoagulase bothrops atrox + nicardipine

Hemocoagulase Bothrops Atrox + nicardipine is a **combination drug** consisting of two active pharmaceutical ingredients: Hemocoagulase Bothrops Atrox and nicardipine. - **Hemocoagulase Bothrops Atrox** is an enzymatic hemostatic agent derived from the venom of the Bothrops atrox snake. It is used to promote blood clotting and reduce bleeding during surgical procedures. Its mechanism involves the formation of stable blood clots to enhance hemostasis, which is particularly useful in surgeries requiring tight control of bleeding[7][4][3]. - **Nicardipine** is a small molecule, calcium channel blocker prescribed for the management of **hypertension (high blood pressure)** and **angina (chest pain)**. It acts by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, thus relaxing blood vessels, reducing cardiac workload, and increasing blood and oxygen supply to the heart[2][8][5][10]. This combination would theoretically provide both hemostatic control (from Hemocoagulase Bothrops Atrox) and blood pressure management (from nicardipine), although no specific clinical context for their combined use is described in the available literature. There is no evidence of a uniquely named or branded pharmaceutical product that combines these two agents into a single formulation.